Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults
暂无分享,去创建一个
Eleni Karatza | Christos Reppas | C. Reppas | M. Vertzoni | C. Markopoulos | C. Goumas | Maria Vertzoni | E. Karatza | Constantinos Goumas | Constantinos Markopoulos | Constantinos Markopoulos
[1] Hans Lennernäs,et al. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids , 2005, Pharmaceutical Research.
[2] Mark McAllister,et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[3] N. Hosten,et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging , 2005, Alimentary pharmacology & therapeutics.
[4] E. Carpenter. Introductory text , 1967, Money and Government.
[5] G. Sladen,et al. Comparison of the effects of medium and long chain triglyceride containing liquid meals on gall bladder and small intestinal function in normal man. , 1984, Gut.
[6] K. Becker,et al. Dietary Roles of Non-Starch Polysachharides in Human Nutrition: A Review , 2012, Critical reviews in food science and nutrition.
[7] Christos Reppas,et al. Characterization of the Contents of Ascending Colon to Which Drugs are Exposed After Oral Administration to Healthy Adults , 2009, Pharmaceutical Research.
[8] M. Nyman,et al. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. , 2006, Biomedical chromatography : BMC.
[9] A. Basit,et al. Drug solubility in luminal fluids from different regions of the small and large intestine of humans. , 2010, Molecular pharmaceutics.
[10] Christos Reppas,et al. Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults. , 2011, International journal of pharmaceutics.
[11] T. Gruffydd-Jones,et al. Assessment of orocaecal transit time in cats by the breath hydrogen method: the effects of sedation and a comparison of definitions. , 1996, Research in veterinary science.
[12] S. Phillips,et al. Capacity of the human colon to absorb fluid , 1978 .
[13] S. Lewis,et al. Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.
[14] K. Goumas,et al. Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example , 2015, The Journal of pharmacy and pharmacology.
[15] Clive G. Wilson,et al. Physiological pharmaceutics : biological barriers to drug absorption , 1989 .
[16] J. Dressman,et al. Characterization of the Ascending Colon Fluids in Ulcerative Colitis , 2010, Pharmaceutical Research.
[17] K. Goumas,et al. Precipitation in and Supersaturation of Contents of the Upper Small Intestine After Administration of Two Weak Bases to Fasted Adults , 2011, Pharmaceutical Research.
[18] W. Muir,et al. Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying drugs in the horse. , 1988, Journal of veterinary internal medicine.
[19] R. D. de Souza,et al. Colonic Health: Fermentation and Short Chain Fatty Acids , 2006, Journal of clinical gastroenterology.
[20] G. Macfarlane,et al. Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon , 1998, Microbial Ecology.
[21] C. Reppas,et al. Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. , 2012, Molecular pharmaceutics.
[22] G. Sladen,et al. Fasting and postprandial ileal function in adapted ileostomates and normal subjects. , 1986, Gut.
[23] J. Dressman,et al. Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies , 2006, Pharmaceutical Research.
[24] H. Davenport. Physiology of the digestive tract : an introductory text , 1971 .
[25] L. A. Christensen,et al. pH‐Profile and regional transit times of the normal gut measured by a radiotelemetry device , 1989, Alimentary pharmacology & therapeutics.
[26] Talia Flanagan,et al. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[27] Patrick Augustijns,et al. Characterization of fasted‐state human intestinal fluids collected from duodenum and jejunum , 2006, The Journal of pharmacy and pharmacology.
[28] J. Fordtran,et al. Ionic constituents and osmolality of gastric and small-intestinal fluids after eating , 1966, The American Journal of Digestive Diseases.
[29] W. Holben,et al. Effective Recovery of Bacterial DNA and Percent-Guanine-Plus-Cytosine-Based Analysis of Community Structure in the Gastrointestinal Tract of Broiler Chickens , 1998, Applied and Environmental Microbiology.
[30] O. Hernell,et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. , 1990, Biochemistry.
[31] J. Dressman,et al. Biorelevant Media to Simulate Fluids in the Ascending Colon of Humans and Their Usefulness in Predicting Intracolonic Drug Solubility , 2010, Pharmaceutical Research.